Exelixis (EXEL) revenue

Revenue · fiscal 2025
$2.32B

Exelixis (EXEL) reported revenue of $2.32B in fiscal 2025 (the year ended December 31, 2025). That is 7.0% higher than the $2.17B of fiscal 2024. Figures as of 18 Nov 2026, 08:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$2.32B
Change on fiscal 2024
+7.0%
Growth, 5 years
+19.1% a year
Growth, 10 years
+51.2% a year
Highest on record
$2.32Bfiscal 2025
Lowest on record
$25.11Mfiscal 2014
Fiscal years on record
192009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Exelixis revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year; over ten years the rate was 51.2% a year. Across the 19 fiscal years on record (2009–2025), the highest was $2.32B in fiscal 2025 and the lowest $25.11M in fiscal 2014.

History · 19 fiscal years

Revenue by fiscal year

Exelixis revenue, year by year

Exelixis (EXEL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$2.32B 7.0% up
2024$2.17B 18.5% up
2023$1.83B 13.6% up
2022$1.61B 12.3% up
2021$1.43B—
2021$987.54M 2.0% up
2020$967.78M—
2018$853.83M 88.7% up
2017$452.48M 136.3% up
2016$191.45M—
2016$191.45M—
2016$37.17M 0.0%
2015$37.17M 48.0% up
2014$25.11M 19.9% down
2013$31.34M 34.0% down
2012$47.45M 83.6% down
2011$289.64M 56.5% up
2010$185.05M 21.9% up
2009$151.76M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Exelixis and comparable companies
CompanyRevenueFiscal year
Medpace Holdings MEDP$2.53B2025
Revvity RVTY$2.86B2025
Exelixis EXEL$2.32B2025
Charles River Laboratories International CRL$4.02B2025
Neurocrine Biosciences NBIX$2.86B2025
Ascendis Pharma ASND€720.13M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EXEL

Exelixis, figure by figure

Exelixis (EXEL) overview: price, valuation and scorecardAll health care companies by market value

Exelixis revenue: questions and answers

What is Exelixis's revenue?

Exelixis (EXEL) reported revenue of $2.32B in fiscal 2025 (the year ended December 31, 2025). That is 7.0% higher than the $2.17B of fiscal 2024.

What is the growth rate of Exelixis's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year; over ten years the rate was 51.2% a year.

What are the highest and lowest revenue figures on record for Exelixis?

Across the 19 fiscal years on record (2009–2025), the highest was $2.32B in fiscal 2025 and the lowest $25.11M in fiscal 2014.

How is Exelixis's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Exelixis (EXEL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/EXEL/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.